The awardees are Daniel Drucker, an endocrinologist at the University of Toronto, Joel Habener, an endocrinologist at Harvard Medical School, Jens Juul Holst, a physiologist at the University of Copenhagen, Lotte Bjerre Knudsen, a pharmaceutical scientist at Novo Nordisk, and Svetlana Mojsov, a chemist at The Rockefeller University
The answer is not that simple
This consultation is an opportunity for providers to ask or answer any further questions as well as to set expectations about the efficacy and potential side effects of treatment
Common Side Effects and How to Manage Them GLP-1 medications are generally well-tolerated when used under medical supervision, but side effects - particularly gastrointestinal effects - are common, especially during the early weeks and after dose increases
This crucial difference provides you with powerful tools and ongoing support for long-term weight loss and well-being
Furthermore, the study cohort included individuals who either switched to or added on treatment with other glucose-lowering drugs
